Fortis Healthcare receives GST orders totaling ₹21.49 crore for FY21-23
Fortis Healthcare received GST orders for FY21-23, totaling ₹21.49 crore. This includes demands, interest, and penalties for FY20-21 (₹4.78 crore), FY21-22 (₹8.50 crore), and FY22-23 (₹8.12 crore). Some show cause notices were dropped.
The total amount of ₹21.49 crore, spread over three financial years, is relatively small compared to Fortis Healthcare's overall revenue and operations, thus having a low financial impact.
The announcement details GST orders and confirmed demands, including penalties and interest. While it's a regulatory filing, the outcome is a confirmed financial liability, which is neutral as it is a consequence of past transactions and the company has responded to notices.
Fortis Healthcare Limited has disclosed the receipt of Goods and Services Tax (GST) orders concerning financial years 2020-21, 2021-22, and 2022-23. The orders, issued by the State Tax Officer, Group IX, Chengalpattu Intelligence Division, Tamil Nadu, pertain to disputed GST amounts.
For FY 2020-21, the company has been confirmed a demand of ₹478.08 lakh (approximately ₹4.78 crore), which includes interest and penalty amounting to ₹142.02 lakh and ₹168.03 lakh, respectively. For FY 2021-22, the confirmed demand is ₹850.00 lakh (approximately ₹8.50 crore), with interest and penalty totaling ₹212.16 lakh and ₹318.92 lakh. For FY 2022-23, the demand stands at ₹811.53 lakh (approximately ₹8.12 crore), including interest and penalty of ₹158.58 lakh and ₹326.47 lakh.
The company had initially received show cause notices for larger amounts, including penalties, but after submitting its response, the GST authority passed orders confirming these specific demands. The show cause notices for the balance amounts have been dropped. The total confirmed demand across the three financial years amounts to approximately ₹21.49 crore.
What to do with a filing like this
Fortis Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Fortis Healthcare Limited. Read the original for the full detail.